Loss of PI3K blocks cell-cycle progression in a Drosophila tumor model

M Willecke1, J Toggweiler, K Basler

  • 1Institute of Molecular Life Sciences, University of Zurich, Switzerland.

Oncogene
|April 26, 2011
PubMed

Insights

Tumorigenesis requires genetic alterations. Targeting phosphoinositide 3-kinase (PI3K) activity in a Drosophila model significantly inhibited tumor growth by affecting cell-cycle progression, revealing a synthetic vulnerability.

Area of Science:

  • Developmental Biology
  • Genetics
  • Cancer Research

Background:

  • Tumorigenesis is a complex process involving genetic mutations.
  • Identifying genes critical for tumor growth is essential for understanding cancer progression.

Purpose of the Study:

  • To identify genes specifically required for tumor growth using a Drosophila model.
  • To investigate the role of phosphoinositide 3-kinase (PI3K) in tumor development.

Main Methods:

  • Utilized a Drosophila tumor model to screen for genes essential for tumor growth.
  • Assessed the impact of reduced phosphoinositide 3-kinase (PI3K) activity on tumor size and cell-cycle progression.

Main Results:

  • Reduction of PI3K activity led to significantly smaller tumors in the Drosophila model.
  • This inhibition of tumor growth was linked to disruptions in cell-cycle progression.
  • Wild-type tissue growth was only slightly affected by the reduction in PI3K activity.

Conclusions:

  • Tumor cells exhibit a dependency on PI3K function for growth.
  • Reducing PI3K activity provides a synthetic interference strategy against tumor growth.
  • Drosophila genetics is a powerful tool for uncovering vulnerabilities in tumorigenesis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...